Dr. Ethan Binder, MD

Dr. Binder practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

Dr. Binder's NPI, 1598028540, was assigned on June 24, 2012. Dr. Binder holds New Mexico license MD2018-0257.

Dr. Binder's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

Dr. Binder's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. Dr. Binder is also affiliated with Presbyterian Santa Fe Medical Center. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Binder to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Binder practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Binder's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Binder's licenses on file in 2 states: New Mexico and Pennsylvania.

CMS data shows 838 Medicare services from Dr. Binder across 10 procedure codes in 2024, for 322 Medicare patients. Medicare paid $69,046 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 322 Medicare patients who saw Dr. Binder in 2024. The largest group is 65 to 74, with 158 patients. 65% of them have high cholesterol, and 62% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Binder's median patient age at 70, with 56% women.

In 2024, Dr. Binder wrote 3,331 Medicare Part D claims for 440 patients. 74% of them were for generic drugs. CMS names the drug for 2,921 of them, across 65 drugs with 11 or more claims each, at $8,478,023 in total drug cost. In 2023, CMS named 2,191 claims across 55 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Binder for performance year 2024, reported as part of a group. Dr. Binder accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Binder as offering telehealth.

CMS Open Payments shows 268 general payments to Dr. Binder from 42 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. ADC Therapeutics America, Inc. paid the most, $11,477.